DSM Pharmaceutical Products, the custom manufacturing and technology business of Royal DSM, announced today that their new cGMP custom biopharmaceutical manufacturing ‘biologics plant of the future’ will open in June 2013.
The DSM facility was built with cooperation from the Queensland and Commonwealth Governments of Australia. Karen King, President of DSM Biologics, the biopharmaceutical manufacturing business of DSM Pharmaceutical Products, stated, …
Tags: growth area, local alliances, biopharmaceutical manufacturing, bioprocessing technology
Source: PR Newswire, press release, 2013-04-22.